StreetWatch: As Federal Funding Floods the Drone Market, Quantum Cyber Is Assembling a Next Generation Platform
Washington's drone strategy is accelerating on two fronts: pouring unprecedented capital into domestic production while aggressively targeting the supply chains behind Iranian UAVs. Quantum Cyber N.V. (NASDAQ: QUCY) appears positioned squarely within that emerging policy corridor. Through its U.S. subsidiary, the company has acquired an equipped 50,000-square-foot manufacturing facility in Connecticut, established a federal procurement vehicle, and outlined plans to produce up to 100,000...
2026-08-03 10:51 AM EDT
StreetWatch: Nuvectis Pharma Eyes $9.8 Billion Oral PNH Market With Late-Stage NXP100 Backed by Strong Positive Phase 3 Data
New report covers Nuvectis Pharma (NASDAQ: NVCT) as the company transitions from a single-drug oncology story into a late-stage rare-disease player following its June licensing deal with Haisco Pharmaceutical Group. Report highlights: Nuvectis Pharma (NASDAQ: NVCT) recently secured worldwide rights outside China to NXP100, a potentially best-in-class once-daily oral therapy for paroxysmal nocturnal hemoglobinuria (PNH), along with oncology asset NXP200, from Haisco Pharmaceutical Group. The...
2026-07-14 10:40 AM EDT